HIV Medicine

Performance of a World Health Organization first-line regimen (stavudine/lamivudine/nevirapine) in antiretroviral-naïve individuals in a Western setting
pp. 267-270(4)
Authors: Tam, LWY; Hogg, RS; Yip, B; Montaner, JSG; Harrigan, PR; Brumme, CJ

Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease
pp. 271-279(9)
Authors: Osborn, MK; Guest, JL; Rimland, D

Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy
pp. 280-287(8)
Authors: Riddler, SA; Li, X; Chu, H; Kingsley, LA; Dobs, A; Evans, R; Palella, F; Visscher, B; Chmiel, JS; Sharrett, AR

Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team
pp. 288-294(7)
Authors: Aweeka, FT; Kang, M; Yu, J-Y; Lizak, P; Alston, B; Chung, RT

Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine
pp. 295-299(5)
Authors: Shafran, SD; Mashinter, LD; Lindemulder, A; Taylor, GD; Chiu, I

Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS
pp. 300-305(6)
Authors: Josephs, JS; Fleishman, JA; Gaist, P; Gebo, KA

The significance of Epstein-Barr virus detected in the cerebrospinal fluid of people with HIV infection
pp. 306-311(6)
Authors: Wang, J; Ozzard, A; Nathan, M; Atkins, M; Nelson, M; Gazzard, B; Bower, M

The treatment of chronic hepatitis C in HIV-infected patients: a meta-analysis
pp. 312-321(10)
Authors: Kim, AI; Dorn, A; Bouajram, R; Saab, S

Malignancies in HIV-infected Thai patients
pp. 322-323(2)
Authors: Kiertiburanakul, S; Likhitpongwit, S; Ratanasiri, S; Sungkanuparph, S